These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 18416392)
1. [New drugs for HIV infection]. Taéron C Rev Infirm; 2008 Mar; (138):47-9. PubMed ID: 18416392 [No Abstract] [Full Text] [Related]
2. Advances in HIV therapeutics: the 14th CROI. Boyle BA; Elion R; Cohen CJ; Moyle GJ; Sax P; Frank I AIDS Read; 2007 May; 17(5):268-70, 272-4, 283-6. PubMed ID: 17532664 [No Abstract] [Full Text] [Related]
3. New drugs offer options. AIDS Read; 2007 Apr; 17(4):206. PubMed ID: 17479506 [No Abstract] [Full Text] [Related]
4. Anti-HIV agents. New drugs--hope and a degree of caution. TreatmentUpdate; 2007; 19(6):9-10. PubMed ID: 18041153 [No Abstract] [Full Text] [Related]
5. Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus. Stephenson J JAMA; 2007 Apr; 297(14):1535-6. PubMed ID: 17426263 [No Abstract] [Full Text] [Related]
6. Two new drugs for HIV infection. Med Lett Drugs Ther; 2008 Jan; 50(1277):2-4. PubMed ID: 18197163 [No Abstract] [Full Text] [Related]
7. The latest in antiretroviral therapy. Temesgen Z Drug News Perspect; 2006 Oct; 19(8):491-8. PubMed ID: 17160151 [TBL] [Abstract][Full Text] [Related]
8. Anti-HIV agents. New drugs, new hope, old lessons. TreatmentUpdate; 2007 Feb; 19(2):1-3. PubMed ID: 17447311 [No Abstract] [Full Text] [Related]
9. Pivotal moments in HIV treatment: the 14th CROI. Laurence J AIDS Read; 2007 May; 17(5):239-40. PubMed ID: 17532657 [No Abstract] [Full Text] [Related]
10. Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an hiv-infected patient failing all four classes of antiretroviral drugs. Di Biagio A; Bruzzone B; Rosso R; Viganò O; Icardi G; Viscoli C; Rusconi S AIDS Patient Care STDS; 2008 May; 22(5):355-7. PubMed ID: 18373415 [No Abstract] [Full Text] [Related]
11. Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc. Armstrong-James D; Stebbing J; Scourfield A; Smit E; Ferns B; Pillay D; Nelson M Antiviral Res; 2010 May; 86(2):224-6. PubMed ID: 20211653 [TBL] [Abstract][Full Text] [Related]
12. Report from the XVI International HIV Drug Resistance Workshop. Kuritzkes DR AIDS Clin Care; 2007 Aug; 19(8):69-70. PubMed ID: 17695089 [No Abstract] [Full Text] [Related]
13. HIV meds: keeping trouble at bay. Daughtry LM; Bankston JB; Deshotels JM RN; 2002 Feb; 65(2):31-5; quiz 36. PubMed ID: 15328865 [No Abstract] [Full Text] [Related]
14. New drugs for HIV therapy. Rockstroh JK J HIV Ther; 2005 Dec; 10(4):66-7. PubMed ID: 16519244 [No Abstract] [Full Text] [Related]
15. AIDS 2006 - XVI International Conference. Time to deliver. Susman E IDrugs; 2006 Oct; 9(10):686-9. PubMed ID: 17016772 [No Abstract] [Full Text] [Related]
16. Changes in HIV-1 tropism: clinical and prognostic consequences. Mosier DE Eur J Med Res; 2007 Oct; 12(9):371-4. PubMed ID: 17933716 [No Abstract] [Full Text] [Related]
17. New HIV drug classes on the horizon. Opar A Nat Rev Drug Discov; 2007 Apr; 6(4):258-9. PubMed ID: 17457997 [No Abstract] [Full Text] [Related]
18. Maraviroc--new HIV drug. Emerging options need to be used wisely. Vázquez E Posit Aware; 2007; 18(4):18-9. PubMed ID: 17682275 [No Abstract] [Full Text] [Related]
19. First medication in new class of ARTs poised to be available for salvage therapy. Tropism testing helps determine best patients for drug. AIDS Alert; 2007 Aug; 22(8):85-8. PubMed ID: 17763555 [No Abstract] [Full Text] [Related]